Global In-Situ Hybridization Market Professional Survey Report 2019
Table of Contents
Executive Summary
1 Industry Overview of In-Situ Hybridization
- 1.1 Definition of In-Situ Hybridization
- 1.2 In-Situ Hybridization Segment by Type
- 1.2.1 Global In-Situ Hybridization Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Radioactive isotopes
- 1.2.3 Non-radioactive labels
- 1.3 In-Situ Hybridization Segment by Applications
- 1.3.1 Global In-Situ Hybridization Consumption Comparison by Applications (2014-2025)
- 1.3.2 Cancer Diagnosis
- 1.3.3 Immunology
- 1.3.4 Neuroscience
- 1.3.5 Cytology
- 1.3.6 Infectious Diseases
- 1.4 Global In-Situ Hybridization Overall Market
- 1.4.1 Global In-Situ Hybridization Revenue (2014-2025)
- 1.4.2 Global In-Situ Hybridization Production (2014-2025)
- 1.4.3 North America In-Situ Hybridization Status and Prospect (2014-2025)
- 1.4.4 Europe In-Situ Hybridization Status and Prospect (2014-2025)
- 1.4.5 China In-Situ Hybridization Status and Prospect (2014-2025)
- 1.4.6 Japan In-Situ Hybridization Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia In-Situ Hybridization Status and Prospect (2014-2025)
- 1.4.8 India In-Situ Hybridization Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of In-Situ Hybridization
- 2.3 Manufacturing Process Analysis of In-Situ Hybridization
- 2.4 Industry Chain Structure of In-Situ Hybridization
3 Development and Manufacturing Plants Analysis of In-Situ Hybridization
- 3.1 Capacity and Commercial Production Date
- 3.2 Global In-Situ Hybridization Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of In-Situ Hybridization
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 In-Situ Hybridization Production and Capacity Analysis
- 4.2 In-Situ Hybridization Revenue Analysis
- 4.3 In-Situ Hybridization Price Analysis
- 4.4 Market Concentration Degree
5 In-Situ Hybridization Regional Market Analysis
- 5.1 In-Situ Hybridization Production by Regions
- 5.1.1 Global In-Situ Hybridization Production by Regions
- 5.1.2 Global In-Situ Hybridization Revenue by Regions
- 5.2 In-Situ Hybridization Consumption by Regions
- 5.3 North America In-Situ Hybridization Market Analysis
- 5.3.1 North America In-Situ Hybridization Production
- 5.3.2 North America In-Situ Hybridization Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America In-Situ Hybridization Import and Export
- 5.4 Europe In-Situ Hybridization Market Analysis
- 5.4.1 Europe In-Situ Hybridization Production
- 5.4.2 Europe In-Situ Hybridization Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe In-Situ Hybridization Import and Export
- 5.5 China In-Situ Hybridization Market Analysis
- 5.5.1 China In-Situ Hybridization Production
- 5.5.2 China In-Situ Hybridization Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China In-Situ Hybridization Import and Export
- 5.6 Japan In-Situ Hybridization Market Analysis
- 5.6.1 Japan In-Situ Hybridization Production
- 5.6.2 Japan In-Situ Hybridization Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan In-Situ Hybridization Import and Export
- 5.7 Southeast Asia In-Situ Hybridization Market Analysis
- 5.7.1 Southeast Asia In-Situ Hybridization Production
- 5.7.2 Southeast Asia In-Situ Hybridization Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia In-Situ Hybridization Import and Export
- 5.8 India In-Situ Hybridization Market Analysis
- 5.8.1 India In-Situ Hybridization Production
- 5.8.2 India In-Situ Hybridization Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India In-Situ Hybridization Import and Export
6 In-Situ Hybridization Segment Market Analysis (by Type)
- 6.1 Global In-Situ Hybridization Production by Type
- 6.2 Global In-Situ Hybridization Revenue by Type
- 6.3 In-Situ Hybridization Price by Type
7 In-Situ Hybridization Segment Market Analysis (by Application)
- 7.1 Global In-Situ Hybridization Consumption by Application
- 7.2 Global In-Situ Hybridization Consumption Market Share by Application (2014-2019)
8 In-Situ Hybridization Major Manufacturers Analysis
- 8.1 Abbott Laboratories
- 8.1.1 Abbott Laboratories In-Situ Hybridization Production Sites and Area Served
- 8.1.2 Abbott Laboratories Product Introduction, Application and Specification
- 8.1.3 Abbott Laboratories In-Situ Hybridization Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 F. Hoffmann-La Roche
- 8.2.1 F. Hoffmann-La Roche In-Situ Hybridization Production Sites and Area Served
- 8.2.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
- 8.2.3 F. Hoffmann-La Roche In-Situ Hybridization Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Leica Biosystems Nussloch
- 8.3.1 Leica Biosystems Nussloch In-Situ Hybridization Production Sites and Area Served
- 8.3.2 Leica Biosystems Nussloch Product Introduction, Application and Specification
- 8.3.3 Leica Biosystems Nussloch In-Situ Hybridization Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Agilent Technologies
- 8.4.1 Agilent Technologies In-Situ Hybridization Production Sites and Area Served
- 8.4.2 Agilent Technologies Product Introduction, Application and Specification
- 8.4.3 Agilent Technologies In-Situ Hybridization Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Thermo Fisher Scientific
- 8.5.1 Thermo Fisher Scientific In-Situ Hybridization Production Sites and Area Served
- 8.5.2 Thermo Fisher Scientific Product Introduction, Application and Specification
- 8.5.3 Thermo Fisher Scientific In-Situ Hybridization Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Merck
- 8.6.1 Merck In-Situ Hybridization Production Sites and Area Served
- 8.6.2 Merck Product Introduction, Application and Specification
- 8.6.3 Merck In-Situ Hybridization Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 PerkinElmer
- 8.7.1 PerkinElmer In-Situ Hybridization Production Sites and Area Served
- 8.7.2 PerkinElmer Product Introduction, Application and Specification
- 8.7.3 PerkinElmer In-Situ Hybridization Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Exiqon A/S
- 8.8.1 Exiqon A/S In-Situ Hybridization Production Sites and Area Served
- 8.8.2 Exiqon A/S Product Introduction, Application and Specification
- 8.8.3 Exiqon A/S In-Situ Hybridization Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 BioGenex Laboratories
- 8.9.1 BioGenex Laboratories In-Situ Hybridization Production Sites and Area Served
- 8.9.2 BioGenex Laboratories Product Introduction, Application and Specification
- 8.9.3 BioGenex Laboratories In-Situ Hybridization Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Advanced Cell Diagnostics
- 8.10.1 Advanced Cell Diagnostics In-Situ Hybridization Production Sites and Area Served
- 8.10.2 Advanced Cell Diagnostics Product Introduction, Application and Specification
- 8.10.3 Advanced Cell Diagnostics In-Situ Hybridization Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Bio SB
9 Development Trend of Analysis of In-Situ Hybridization Market
- 9.1 Global In-Situ Hybridization Market Trend Analysis
- 9.1.1 Global In-Situ Hybridization Market Size (Volume and Value) Forecast 2019-2025
- 9.2 In-Situ Hybridization Regional Market Trend
- 9.2.1 North America In-Situ Hybridization Forecast 2019-2025
- 9.2.2 Europe In-Situ Hybridization Forecast 2019-2025
- 9.2.3 China In-Situ Hybridization Forecast 2019-2025
- 9.2.4 Japan In-Situ Hybridization Forecast 2019-2025
- 9.2.5 Southeast Asia In-Situ Hybridization Forecast 2019-2025
- 9.2.6 India In-Situ Hybridization Forecast 2019-2025
- 9.3 In-Situ Hybridization Market Trend (Product Type)
- 9.4 In-Situ Hybridization Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 In-Situ Hybridization Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
In Situ Hybridization (ISH)
In Situ Hybridization (ISH) is a technique that allows for precise localization of a specific segment of nucleic acid within a histologic section.
The underlying basis of ISH is that nucleic acids, if preserved adequately within a histologic specimen, can be detected through the application of a complementary strand of nucleic acid to which a reporter molecule is attached.
Visualization of the reporter molecule allows to localize DNA or RNA sequences in a heterogeneous cell populations including tissue samples and environmental samples. Riboprobes also allow to localize and assess degree of gene expression. The technique is particularly useful in neuroscience.
The global In-Situ Hybridization market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on In-Situ Hybridization volume and value at global level, regional level and company level. From a global perspective, this report represents overall In-Situ Hybridization market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of In-Situ Hybridization in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their In-Situ Hybridization manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Abbott Laboratories
F. Hoffmann-La Roche
Leica Biosystems Nussloch
Agilent Technologies
Thermo Fisher Scientific
Merck
PerkinElmer
Exiqon A/S
BioGenex Laboratories
Advanced Cell Diagnostics
Bio SB
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Radioactive isotopes
Non-radioactive labels
Segment by Application
Cancer Diagnosis
Immunology
Neuroscience
Cytology
Infectious Diseases